There is a vulnerable group we must not leave behind in our response to COVID-19: people who are dependent on illicit drugs.
Users of illicit substances are vulnerable to a variety of health concerns. This article discusses how the COVID-19 pandemic places illicit drug users at increased risk for COVID-19 due to their predisposition to infection and social contact; how disruptions to illicit drug supply chains increase risk for overdose due to drug substitution and; the impact of missing out on drug treatment services. The piece highlights the role of pharmacists in keeping this marginalized patient population safe.
Guirguis A. The Pharmaceutical Journal. 2020;304(7937).